Rani Therapeutics Holdings annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Capital Expenditures (CapEx) Growth & History (RANI)
Rani Therapeutics Holdings's capital expenditures (capex) was $88,000 for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $88,000 | −$180,000 | −67.16% |
| 2024 | 2024-12-31 | $268,000 | −$961,000 | −78.19% |
| 2023 | 2023-12-31 | $1.2M | −$390,000 | −24.09% |
| 2022 | 2022-12-31 | $1.6M | $1.1M | +219.96% |
| 2021 | 2021-12-31 | $506,000 | −$694,000 | −57.83% |
| 2020 | 2020-12-31 | $1.2M | — | — |
Rani Therapeutics Holdings quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $32,000 | −$5,000 | −13.51% |
| Q1 2026 | 2026-03-31 | $15,000 | −$36,000 | −70.59% |
| Q4 2025 | 2025-12-31 | $0 | −$31,000 | — |
| Q3 2025 | 2025-09-30 | $0 | −$125,000 | — |
| Q2 2025 | 2025-06-30 | $37,000 | −$57,000 | −60.64% |
| Q1 2025 | 2025-03-31 | $51,000 | $33,000 | +183.33% |
| Q4 2024 | 2024-12-31 | $31,000 | −$136,000 | −81.44% |
| Q3 2024 | 2024-09-30 | $125,000 | −$354,000 | −73.90% |
| Q2 2024 | 2024-06-30 | $94,000 | −$241,000 | −71.94% |
| Q1 2024 | 2024-03-31 | $18,000 | −$230,000 | −92.74% |
| Q4 2023 | 2023-12-31 | $167,000 | −$363,000 | −68.49% |
| Q3 2023 | 2023-09-30 | $479,000 | $23,000 | +5.04% |
| Q2 2023 | 2023-06-30 | $335,000 | −$44,000 | −11.61% |
| Q1 2023 | 2023-03-31 | $248,000 | −$6,000 | −2.36% |
| Q4 2022 | 2022-12-31 | $530,000 | $259,000 | +95.57% |
| Q3 2022 | 2022-09-30 | $456,000 | $456,000 | — |
| Q2 2022 | 2022-06-30 | $379,000 | $243,000 | +178.68% |
| Q1 2022 | 2022-03-31 | $254,000 | $155,000 | +156.57% |
| Q4 2021 | 2021-12-31 | $271,000 | — | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $136,000 | — | — |
| Q1 2021 | 2021-03-31 | $99,000 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
Rani Therapeutics Holdings capital expenditures (capex) trends
Over the last five fiscal years, Rani Therapeutics Holdings's capital expenditures (capex) decreased from $1.2M to $88,000, a change of −$1.1M. The latest reported quarter, Q2 2026, shows $32,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗